ULISES BONILLA BURGOS, MD
Multi-Specialty Group in MERCEDES, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ULISES BONILLA BURGOS, MD filed 11,896 Medicare Part D claims in 2023 as a Multi-Specialty Group in MERCEDES, Texas, prescribing 85% generic.
- 12K
- Part D claims, 2023
- 85%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ULISES BONILLA BURGOS, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
11,896 Top 2% higher than 98% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ULISES BONILLA BURGOS, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Texas
How Multi-Specialty Group compares to other specialties among Texas providers
Multi-Specialty Group share within Texas
Multi-Specialty Group is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Multi-Specialty Group (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Multi-Specialty Group ABMS/AOA estimate
Est. board-certified rate (Multi-Specialty Group) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Multi-Specialty Group US NPIs
Specialty board-certified rate — Multi-Specialty Group estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ULISES BONILLA BURGOS, MD appears in the CMS NPPES registry as a Multi-Specialty Group provider holding MD credentials at 208 STARR ST, MERCEDES, TX, 78570, with a listed phone of (956) 903-4218. NPI 1750715868 was issued on 08/26/2013. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BONILLA BURGOS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 11,896 prescription claims written by this provider, covering 1,109 Medicare beneficiaries and totaling roughly $1.9 million in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 1.2%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Multi-Specialty Group is a narrow specialty nationwide, with 8 enrolled providers across 6 states and an average of 1,814 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1750715868 |
|---|---|
| Specialty | Multi-Specialty Group |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/26/2013 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ULISES BONILLA BURGOS, MD's current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ULISES BONILLA BURGOS, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to ULISES BONILLA BURGOS, MD. To verify ULISES BONILLA BURGOS, MD's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 11,896 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 28,722
- Total Day Supply
- 846,735
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $247K
- Opioid Claims
- 145 (1.2% rate)
- Antibiotic Claims
- 191
Patient Demographics
- Average Patient Age
- 71.4 years
- Avg HCC Risk Score
- 1.72
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 157, 65-74: 575, 75-84: 274, 85+: 103
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ULISES BONILLA BURGOS, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
932 claims
- Lisinopril
Lisinopril
631 claims
- Amlodipine Besylate
Amlodipine Besylate
500 claims
- Losartan Potassium
Losartan Potassium
473 claims
- Metformin Hcl
Metformin Hcl
445 claims
- Levothyroxine Sodium 361
Levothyroxine Sodium
361 claims
- Gabapentin 325
Gabapentin
325 claims
- Tamsulosin Hcl 251
Tamsulosin Hcl
251 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 932 |
| Lisinopril | 631 |
| Amlodipine Besylate | 500 |
| Losartan Potassium | 473 |
| Metformin Hcl | 445 |
| Levothyroxine Sodium | 361 |
| Gabapentin | 325 |
| Tamsulosin Hcl | 251 |
| Omeprazole | 246 |
| Simvastatin | 245 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Multi-Specialty Group Overview
How ULISES BONILLA BURGOS, MD fits within the Multi-Specialty Group landscape nationally.
ULISES BONILLA BURGOS, MD's 11,896 claims are above the specialty average of 1,814.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is ULISES BONILLA BURGOS, MD's specialty? ▼
How much does ULISES BONILLA BURGOS, MD prescribe under Medicare Part D? ▼
Where is ULISES BONILLA BURGOS, MD located? ▼
What is ULISES BONILLA BURGOS, MD's NPI number? ▼
Does ULISES BONILLA BURGOS, MD prescribe more brand-name or generic drugs? ▼
Does ULISES BONILLA BURGOS, MD prescribe opioids? ▼
How many Multi-Specialty Group providers are there in the US? ▼
What drugs does ULISES BONILLA BURGOS, MD prescribe most often? ▼
Does ULISES BONILLA BURGOS, MD accept Medicare? ▼
How can I verify ULISES BONILLA BURGOS, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology